Patrick Lacor

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 371 citations · Full text

Hiv/aids Counselling, Treatment And Prevention, Week 48 +14

Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports

Jo Caers, Christel Fontaine, Vincent Vinh‐Hung et al. · Supportive Care in Cancer · 2004 · 177 citations

Pulmonary Embolism, Thrombosis, Venous Thrombosis +10

Spirituality/Religiosity: A Cultural and Psychological Resource among Sub-Saharan African Migrant Women with HIV/AIDS in Belgium

Agnes Ebotabe Arrey, Johan Bilsen, Patrick Lacor et al. · PLoS ONE · 2016 · 135 citations · Full text

Religiosity, Education, Social Determinants Of Health +19

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption

Sabine Allard, Brenda De Keersmaecker, Anna L. de Goede et al. · Clinical Immunology · 2011 · 118 citations

Primary Immunodeficiency, Human Retrovirus, Immunology +11

Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma

Hilde Revets, D. Marissens, S De Wit et al. · Journal of Clinical Microbiology · 1996 · 116 citations · Full text

Immunology, Pathology, Nucleic Acid Amplification Test +16